Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 19;12(3):214-224.
doi: 10.1136/flgastro-2019-101371. eCollection 2021.

IBD in pregnancy: recent advances, practical management

Affiliations
Review

IBD in pregnancy: recent advances, practical management

Christian P Selinger et al. Frontline Gastroenterol. .

Abstract

Inflammatory bowel disease (IBD) poses complex issues in pregnancy, but with high-quality care excellent pregnancy outcomes are achievable. In this article, we review the current evidence and recommendations for pregnant women with IBD and aim to provide guidance for clinicians involved in their care. Many women with IBD have poor knowledge about pregnancy-related issues and a substantial minority remains voluntarily childless. Active IBD is associated with an increased risk of preterm birth, low for gestation weight and fetal loss. With the exception of methotrexate and tofacitinib the risk of a flare outweighs the risk of IBD medication and maintenance of remission from IBD should be the main of care. Most women with IBD will experience a normal pregnancy and can have a vaginal delivery. Active perianal Crohn's disease is an absolute and ileal pouch surgery a relative indication for a caesarean section. Breast feeding is beneficial to the infant and the risk from most IBD medications is negligible.

Keywords: crohn's disease; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CPS has received unrestricted research grants from Warner Chilcott, Janssen and AbbVie, has provided consultancy to Warner Chilcott, Falk, AbbVie, Takeda, Fresenius Kabi and Janssen, and had speaker arrangements with Warner Chilcott, Falk, AbbVie, MSD, Pfizer and Takeda. CN-P had speaker arrangements with Falk, UCB, Sanofi, Alliance and Alexion. KBK has provided consultancy to Amgen and PredictImmune, and had speaker arrangements with Janssen and Takeda. JL has received research grants from Takeda, consultancy and speaker fees from Abbvie, Janssen, MSD, Pfizer and Takeda. AK has provided consultancy to Abbvie, and had speaker arrangements with Pfizer, Janssen and Takeda.

References

    1. Hudson M, Flett G, Sinclair TS, et al. . Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997;58:229–37. 10.1016/S0020-7292(97)00088-X - DOI - PubMed
    1. Dubinsky M, Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis 2008;14:1736–50. 10.1002/ibd.20532 - DOI - PubMed
    1. Ban L, Tata LJ, Humes DJ, et al. . Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study. Aliment Pharmacol Ther 2015;42:855–66. 10.1111/apt.13354 - DOI - PubMed
    1. Bartels SAL, DʼHoore A, Cuesta MA, et al. . Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg 2012;256:1045–8. 10.1097/SLA.0b013e318250caa9 - DOI - PubMed
    1. Beyer-Berjot L, Maggiori L, Birnbaum D, et al. . A total laparoscopic approach reduces the infertility rate after ileal pouch-anal anastomosis: a 2-center study. Ann Surg 2013;258:275–82. 10.1097/SLA.0b013e3182813741 - DOI - PubMed

LinkOut - more resources